Soleno Therapeutics (SLNO) had the highest return between September 15, 2023 and September 21, 2024 by a mid-cap US stock, returning 1,012.3%.
| ASSET | DATE | % RETURN |
|---|---|---|
Soleno Therapeutics (SLNO) | 9/15/2023 - 9/21/2024 | 1,012.28% |
Sezzle Inc Common Stock (SEZL) | 9/15/2023 - 9/21/2024 | 930.91% |
Ast Spacemobile (ASTS) | 9/15/2023 - 9/21/2024 | 586.53% |
Avidity Biosciences (RNA) | 9/15/2023 - 9/21/2024 | 505.99% |
Longboard Pharmaceuticals (LBPH) | 9/15/2023 - 9/21/2024 | 451.95% |
ADMA Biologics (ADMA) | 9/15/2023 - 9/21/2024 | 428.57% |
Janux Therapeutics (JANX) | 9/15/2023 - 9/21/2024 | 382.23% |
Viking Therapeutics (VKTX) | 9/15/2023 - 9/21/2024 | 368.86% |
Lumen Technologies (LUMN) | 9/15/2023 - 9/21/2024 | 359.31% |
Edgewise Therapeutics (EWTX) | 9/15/2023 - 9/21/2024 | 320.21% |
Dyne Therapeutics (DYN) | 9/15/2023 - 9/21/2024 | 285.97% |
Zeta Global (ZETA) | 9/15/2023 - 9/21/2024 | 275.36% |
Oscar Health (OSCR) | 9/15/2023 - 9/21/2024 | 269.84% |
Banco Macro SA B ADR (BMA) | 9/15/2023 - 9/21/2024 | 250.69% |
Talen Energy Corporation Common Stock (TLN) | 9/15/2023 - 9/21/2024 | 234.71% |
Grupo Financiero Galicia SA ADR (GGAL) | 9/15/2023 - 9/21/2024 | 211.49% |
Impinj (PI) | 9/15/2023 - 9/21/2024 | 211.33% |
Sweetgreen (SG) | 9/15/2023 - 9/21/2024 | 203.61% |
New Gold (NGD) | 9/15/2023 - 9/21/2024 | 201.94% |
Coeur Mining (CDE) | 9/15/2023 - 9/21/2024 | 196.6% |
Apogee Therapeutics, Inc Common Stock (APGE) | 9/15/2023 - 9/21/2024 | 186.42% |
Modine Manufacturing (MOD) | 9/15/2023 - 9/21/2024 | 186.36% |
BBVA Banco Frances SA ADR (BBAR) | 9/15/2023 - 9/21/2024 | 179.2% |
Abercrombie & Fitch (ANF) | 9/15/2023 - 9/21/2024 | 178.91% |
TransMedics (TMDX) | 9/15/2023 - 9/21/2024 | 178.39% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
